CCXI
$43.24
Chemocentryx
$.64
1.50%
CCXI
Earnings Whisper ®
N/A
1st Quarter March 2020
Consensus:  ($0.30)
Revenue:  $8.90 Mil
Tuesday
Jun 9
4:05 PM ET
Score
Grade
Tweet Share Watch
Tweet Share Watch

What do you expect when CCXI reports earnings?
Beat
Meet
Miss

Where is CCXI's stock price going from here?
Up
Flat
Down
Stock chart of CCXI
Analysts
Summary of analysts' recommendations for CCXI
Score
Grade
Pivots
Resistance
$46.20
$45.02
$44.13

$42.95

Support
$42.06
$40.88
$39.99
Tweet
Growth
Description
ChemoCentryx, Inc. is a biopharmaceutical company focused on discovering, developing and commercializing orally-administered therapeutics to treat autoimmune diseases, inflammatory disorders and cancer. ChemoCentryx, Inc. is headquartered in Mountain View, California.
Peers
Alexion PharmaceuticalsIncyteExact SciencesCharles River Laboratories InternationalExelixisCoherus BiosciencesLuminex